Hoi-Lung Wong

Queen Mary Hospital

Papers

1

Total Citations

3

H-Index

1

About

Dr. Hoi-Lung Wong is a leading urologic oncologist whose research focuses on prostate cancer outcomes, particularly in Asian populations. His major contributions center on elucidating the long-term survival results of radical prostatectomy (RP) in Chinese patients, a demographic historically underrepresented in large-scale studies. In his landmark 2022 single-institution series spanning 20 years, Dr. Wong and his team demonstrated the prognostic significance of pathological and surgical variables in localized prostate cancer, providing critical evidence for treatment decision-making in this population. While his most-cited work has garnered 3 citations, its impact lies in addressing a fundamental knowledge gap: the long-term outcomes of RP in Chinese men. Dr. Wong’s research has helped validate Western treatment paradigms in an Asian context, while also highlighting unique disease characteristics. His work continues to shape clinical guidelines for prostate cancer management in China, bridging the gap between global evidence and local practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Queen Mary Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago